Short Interest in Shanghai Pharmaceuticals Holding Co., Ltd Rises By 30.2 percent - Defense World
| S1R Stock | EUR 1.58 0.01 0.63% |
Roughly 61% of Shanghai Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Shanghai Pharmaceuticals Holding suggests that many traders are alarmed regarding Shanghai Pharmaceuticals' prospects. The current market sentiment, together with Shanghai Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Shanghai Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Shanghai Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Shanghai daily returns and investor perception about the current price of Shanghai Pharmaceuticals Holding as well as its diversification or hedging effects on your existing portfolios.
Shanghai |
Short Interest in Shanghai Pharmaceuticals Holding Co., Ltd Rises By 30.2 Defense World
Read at news.google.com
 |
Shanghai Pharmaceuticals Fundamental Analysis
We analyze Shanghai Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Shanghai Pharmaceuticals is rated below average in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Shanghai Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Shanghai Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Shanghai Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Shanghai Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Shanghai Pharmaceuticals Related Equities
| X2S1 | SINOPHARM GROUP | 1.55 | ||||
| X2S | Sinopharm Group | 1.54 | ||||
| CLH | Cardinal Health | 0.94 | ||||
| 59Z | MEDIPAL HOLDINGS | 0.70 | ||||
| ABG | AmerisourceBergen | 0.37 | ||||
| S1R | Shanghai Pharmaceuticals | 0.63 | ||||
| PBV | Prestige Consumer | 0.66 | ||||
| PD2 | Patterson Companies | 1.34 | ||||
| HS2 | Henry Schein | 2.60 |
Complementary Tools for Shanghai Stock analysis
When running Shanghai Pharmaceuticals' price analysis, check to measure Shanghai Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Pharmaceuticals is operating at the current time. Most of Shanghai Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shanghai Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shanghai Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |